Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Zoe Vanderweide Zoe Vanderweide is a writer focused on style and accessories.

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...